Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Dew, thanks for responding. It would seem that over the short term there will be three Copax 40 mg products on the US market once MNTA is approved. The value to MNTA should still be substantial but not a windfall. After copax and beyond milestone payments, do you see that next value creating event as market approval for the Orencia copy? And, Illegitimi non carborundum etc from an old correspondent and friend. bp